Euthyroid Graves' Ophthalmopathy With Negative Antibodies (EGONA): A Comprehensive Case-Based Review. [PDF]
CureusBonny M +6 more
europepmc +1 more source
New-Onset Graves' Ophthalmopathy After Treatment with Pembrolizumab: A Case Report and a Review of the Literature. [PDF]
Diagnostics (Basel)Pan M, Zhou X, Wu Y.
europepmc +1 more source
Clinical value of dual-energy CT parameters combined with morphological features in predicting graves' ophthalmopathy. [PDF]
BMC Med ImagingMa Z +7 more
europepmc +1 more source
Immunopathogenesis of Graves\u27 Ophthalmopathy
, 1984 Clinical Background. Course of Ophthalmopathy. This may occur at any time in relation to thyrotoxicosis and myoxedema. May improve, worsen, or not change with thyrotoxicosis management, and its uncertain relationship to medical, radioactive iodine, and ...
Robert C. Sergott
core
Emerging therapeutic approaches in graves' ophthalmopathy: an update on pharmacological interventions. [PDF]
Front ImmunolWang L, Chen L.
europepmc +1 more source
Effect of orbital fat decompression on eyelid contour according to midpupil lid distance in graves' ophthalmopathy. [PDF]
BMC OphthalmolWang YW, Huang WL, Liao SL, Wei YH.
europepmc +1 more source
Lamina cribrosa curvature depth and index as novel parameters in Graves' ophthalmopathy. [PDF]
Sci RepErgen A, Yılmaz Tuğan B.
europepmc +1 more source
Effect of enalapril and losartan on the expression of genes involved in inflammation, fibrogenesis, and apoptosis in orbital fibroblasts of graves' ophthalmopathy. [PDF]
BMC Res NotesSanie-Jahromi F, Khademi B, Owji N.
europepmc +1 more source
Current and promising therapies based on the pathogenesis of Graves' ophthalmopathy. [PDF]
Front Pharmacol, 2023 Zhang X, Zhao Q, Li B.
europepmc +1 more source
Quantitative assessment of graves' ophthalmopathy activity using 99mTc-DTPA SPECT/CT orbital imaging: a feasibility study with multiple indicators. [PDF]
EJNMMI ResLi Y +10 more
europepmc +1 more source